Cytogenetic Market Size, Share, Growth, Trends, and Global Industry Analysis: By Product (Consumables, Testing Kits, Media, and Reagents, Probes, Others (Affinity Reagents and Stains), Instruments, Software & Services), By Techniques (Comparative, Genomic Hybridization (CGH), Fluorescence in Situ Hybridization (FISH), Karyotyping, Immunohistochemistry, Others), By Application (Genetic Disorders, Cancer, Personalized Medicine, Others), By End User (Clinical & Research Laboratories, Pharmaceutical &, Biotechnology Companies, Academic Research Institutes, Others) and Region Forecast 2019-2030

Cytogenetics Market was valued at US$ 2.5 billion in 2023 and is poised to grow at a significant CAGR of 9.8% from 2024-2030. Bridging the gap between clinical applications of genetic results and offering an advanced medical service is the most crucial aim of human genetics. The adoption of cytogenetic techniques is directly impacted by the growth in the use of genetic information in predictive models for disease features, increasing income generation. The market has been considerably pushed by rising cancer mortality rates and the associated increase in cancer incidence. The ongoing increase in cancer cases has highlighted the requirement for creating cutting-edge technology for a thorough understanding of cancer at the genomic level.

Furthermore, the most well-known cytogenetic methods include FISH and CGH, which offer comprehensive details on the molecular signatures of cancer. These techniques help with gaining an understanding of how cancer develops. As several cytogenetic procedures have been effectively used for pharmacogenomic biomarker investigations, expanding pharmacogenomics activities are predicted to impact market growth significantly. A sizable number of published studies proving the function of cytogenetic methods in pharmacogenomic testing demonstrate the practical application of CGH, FISH, and sequencing technology in pharmacogenomics. The application range of cytogenetics techniques has been expanded due to ongoing improvements in CGH and FISH regarding resolution and specificity in basic research and molecular diagnostics. These developments have effectively overcome the limits of traditional cytogenetic analysis. 

Moreover, it is anticipated that the worldwide market will expand in the upcoming years due to an increase in healthcare spending, the prevalence of chronic diseases, and a favorable reimbursement environment. Additionally, market players use cutting-edge methods and tactics to develop original approaches to cytogenetic analysis, which is predicted to drive the market. However, emerging markets are anticipated to offer the industry excellent market possibilities during the projection period.

Cytogenetics Market Key Developments

• In March 2020, Agilent Technologies Inc. launched three new microarrays to meet the requirement of cytogenetics laboratories that conduct prenatal and postnatal research.